285 related articles for article (PubMed ID: 2899164)
21. Nimodipine and inhibition of alpha adrenergic activation of the isolated canine saphenous vein.
Cooke JP; Rimele TJ; Flavahan NA; Vanhoutte PM
J Pharmacol Exp Ther; 1985 Sep; 234(3):598-602. PubMed ID: 2863368
[TBL] [Abstract][Full Text] [Related]
22. Alpha adrenoceptor subtypes and receptor reserve in human versus canine saphenous vein: sensitivity to blockade by nitroglycerin.
Eskinder H; Hillard CJ; Olinger GN; Christensen CW; Baker JE; Warltier DC; Gross GJ
J Pharmacol Exp Ther; 1988 Dec; 247(3):941-8. PubMed ID: 2905005
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the alpha adrenoceptor activity of dopamine, ibopamine and epinine in the pulmonary circulation of the dog.
Shebuski RJ; Fujita T; Smith JM; Ruffolo RR
J Pharmacol Exp Ther; 1987 Apr; 241(1):6-12. PubMed ID: 3033210
[TBL] [Abstract][Full Text] [Related]
24. The inhibitory effect of newer calcium antagonists (nimodipine and PY-108-068) on vasoconstriction in vivo mediated by postsynaptic alpha 2-adrenoceptors.
Van Meel JC; Wilffert B; De Zoeten K; Timmermans PB; Van Zwieten PA
Arch Int Pharmacodyn Ther; 1982 Dec; 260(2):206-17. PubMed ID: 6299220
[TBL] [Abstract][Full Text] [Related]
25. Additional evidence for functional subclassification of alpha-2 adrenoceptors based on a new selective antagonist, SK&F 104856.
Hieble JP; Sulpizio AC; Edwards R; Chapman H; Young P; Roberts SP; Blackburn TP; Wood MD; Shah DH; Demarinis RM
J Pharmacol Exp Ther; 1991 Nov; 259(2):643-52. PubMed ID: 1682482
[TBL] [Abstract][Full Text] [Related]
26. Systemic and regional hemodynamic characterization of alpha-1 and alpha-2 adrenoceptor agonists in pithed rats.
Richer C; Lefevre-Borg F; Lechaire J; Gomeni C; Gomeni R; Giudicelli JF; Cavero I
J Pharmacol Exp Ther; 1987 Mar; 240(3):944-53. PubMed ID: 2882016
[TBL] [Abstract][Full Text] [Related]
27. Lack of a pharmacological distinction between alpha-1 adrenoceptors mediating intracellular calcium-dependent and independent contractions to sympathetic nerve stimulation in the perfused rat caudal artery.
Sulpizio A; Hieble JP
J Pharmacol Exp Ther; 1991 Jun; 257(3):1045-52. PubMed ID: 1675285
[TBL] [Abstract][Full Text] [Related]
28. Lack of effect of a selective vasopressin V1A receptor antagonist SR 49,059, on potentiation by vasopressin of adrenoceptor-mediated pressor responses in the rat mesenteric arterial bed.
Heinemann A; Horina G; Stauber RE; Pertl C; Holzer P; Peskar BA
Br J Pharmacol; 1998 Nov; 125(6):1120-7. PubMed ID: 9863637
[TBL] [Abstract][Full Text] [Related]
29. Differential inhibition of vascular smooth muscle responses to alpha 1- and alpha 2-adrenoceptor agonists by diltiazem and verapamil.
Cavero I; Shepperson N; Lefèvre-Borg F; Langer SZ
Circ Res; 1983 Feb; 52(2 Pt 2):I69-76. PubMed ID: 6131754
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the role of alpha-1 and alpha-2 adrenoceptors in the maintenance of neurogenic tone to the hindlimb vasculature.
Hamed AT; Jandhyala BS; Lokhandwala MF
J Pharmacol Exp Ther; 1986 Aug; 238(2):599-605. PubMed ID: 3016243
[TBL] [Abstract][Full Text] [Related]
31. Characterization of adrenoceptor subtypes in cat cutaneous vasculature.
Koss MC
J Pharmacol Exp Ther; 1990 Jul; 254(1):221-7. PubMed ID: 2366182
[TBL] [Abstract][Full Text] [Related]
32. Insights into the unusual alpha adrenoceptor subtype in dog saphenous vein using phenoxybenzamine.
Low AM; Lu-Chao H; Loke JC; Kwan CY; Daniel EE
J Pharmacol Exp Ther; 1999 Jan; 288(1):148-56. PubMed ID: 9862765
[TBL] [Abstract][Full Text] [Related]
33. Effects of PN 200-110, a new calcium antagonist, on alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction elicited by selective alpha-adrenoceptor agonists and catecholamines in the pithed rat.
Jie K; van Brummelen P; Timmermans PB; Thoolen MJ; van Zwieten PA
Arch Int Pharmacodyn Ther; 1985 Nov; 278(1):72-86. PubMed ID: 2869738
[TBL] [Abstract][Full Text] [Related]
34. alpha 1- and alpha 2-adrenoceptor stimulation in the isolated perfused hindquarters of the rat: an in vitro model.
van Meel JC; Timmermans PB; van Zwieten PA
J Cardiovasc Pharmacol; 1983; 5(4):580-5. PubMed ID: 6193354
[TBL] [Abstract][Full Text] [Related]
35. Evidence for existence of postjunctional alpha 1- and alpha 2-adrenoceptors in cat pulmonary vascular bed.
Hyman AL; Kadowitz PJ
Am J Physiol; 1985 Oct; 249(4 Pt 2):H891-8. PubMed ID: 2864862
[TBL] [Abstract][Full Text] [Related]
36. Localization and characterization of alpha-2 adrenoceptors in the isolated canine pulmonary vein.
Ohlstein EH; Horohonich S; Shebuski RJ; Ruffolo RR
J Pharmacol Exp Ther; 1989 Jan; 248(1):233-9. PubMed ID: 2536428
[TBL] [Abstract][Full Text] [Related]
37. Relation between density (maximum binding) of alpha adrenoceptor binding sites and contractile response in four canine vascular tissues.
Shi AG; Kwan CY; Daniel EE
J Pharmacol Exp Ther; 1989 Sep; 250(3):1119-24. PubMed ID: 2550616
[TBL] [Abstract][Full Text] [Related]
38. Vascular smooth muscle: availability of calcium through alpha-adrenoceptor stimulation.
Haeusler G; de Peyer JE; Yajima M; Schultz G
J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S107-10. PubMed ID: 2433510
[TBL] [Abstract][Full Text] [Related]
39. alpha-Adrenoceptor subtypes mediating regional kidney blood flow responses to renal nerve stimulation.
Eppel GA; Lee LL; Evans RG
Auton Neurosci; 2004 May; 112(1-2):15-24. PubMed ID: 15233926
[TBL] [Abstract][Full Text] [Related]
40. Evidence for heterogeneity of prejunctional alpha-2-adrenoceptors.
Oriowo MA; Hieble JP; Ruffolo RR
Pharmacology; 1991; 43(1):1-13. PubMed ID: 1683709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
